Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-FR
Language French French
Date Updated 2020-10-13 2020-08-11
Drug Identification Number 02353903 02353903
Brand name FEIBA NF FEIBA NF
Common or Proper name anti-inhibitor coagulant complex anti-inhibitor coagulant complex
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients ANTI-INHIBITOR COAGULANT COMPLEX ANTI-INHIBITOR COAGULANT COMPLEX
Strength(s) 3250UNIT 3250UNIT
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size Labelled 2500 U Labelled 2500 U
ATC code B02BD B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-08-11 2020-08-11
Actual start date 2020-08-11 2020-08-11
Estimated end date 2020-09-30 2020-09-30
Actual end date 2020-10-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Feiba 1000 U is currently available. Feiba 1000 U is currently available.
Health Canada comments